Sharps Technology, Inc. (STSS)
$1.2501
+0.00 (+0.01%)
Rating:
Recommendation:
-
| Symbol | STSS |
|---|---|
| Price | $1.2501 |
| Beta | 0.000 |
| Volume Avg. | 0.17M |
| Market Cap | 14.571M |
| Shares () | - |
| 52 Week Range | 0.82-3.62 |
| 1y Target Est | - |
| DCF Unlevered | STSS DCF -> | |
|---|---|---|
| DCF Levered | STSS LDCF -> | |
| ROE | -0.00% | Neutral |
| ROA | -24.10% | Sell |
| Operating Margin | - | |
| Debt / Equity | 39.23% | Neutral |
| P/E | -2.12 | Sell |
| P/B | 1.18 | Strong Buy |
Latest STSS news
About
Download (Excel)Mr. Robert M. Hayes
Healthcare
Medical Instruments & Supplies
NASDAQ Capital Market
Sharps Technology Inc., a medical device company, researches, designs, develops, manufactures, distributes, and sells safety syringe products in the United States. It offers Sharps Provensa, an ultra-low waste space syringe for the administration of various vaccines and injectable medications. The company was incorporated in 2017 and is based in Melville, New York.